Eli Lilly & Co. (LLY)

1027.51 +18.13 (+1.80%) USD  |  NYSE  |  Dec 12, 16:00
1029.21 +1.70 (+0.17%) After-Hours: 20:00
More

Eli Lilly Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade